New developments in the treatment of type 1 diabetes in children

Archives of Disease in Childhood

Volumn 92, Issue 11, 2007, Pages 1015-1019

  Danne, Thomas ^a   Lange, Karin ^b   Kordonouri, Olga ^a  

^a KINDERKRANKENHAUS AUF DER BULT   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HUMAN INSULIN; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN;

CHILD; DIET THERAPY; DRUG ABSORPTION; DRUG ELIMINATION; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; REVIEW;

CHILD; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; ISLETS OF LANGERHANS TRANSPLANTATION; PATIENT EDUCATION AS TOPIC;

EID: 35748960486     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2006.094904     Document Type: Review

References (39)

1. The DCCT Research Group. The effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial. J Pediatr 1994;125(2):177-88.
2. DCCT/EDIC Research Group. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial. J Pediatr 2001;139(6):804-12.
3. Danne T, Weber B, Hartmann R, et al. Long-term glycemic control has a nonlinear association to the frequency of background retinopathy in adolescents with diabetes. Follow-up of the Berlin Retinopathy Study. Diabetes Care 1994;17:1390-6.
4. Dahl-Jorgensen K, Larsen JR, Hanssen KF. Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment? Diabetologia 2005;48(8):1445-53.
5. International Society for Pediatric and Adolescent Diabetes (ISPAD). 2000 consensus guidelines for the management of insulin-dependent diabetes in childhood and adolescence, Available from http://www.ispad.org/ Links.html (accessed 6 June 2007).
6. National Institute for Clinical Excellence. Type 1 diabetes: diagnosis and management of type 1 diabetes in children, young people and adults. 2004. Available from http://www.nice.org.uk/pdf/CG015NICEguideline.pdf (accessed 6 June 2007).
7. Mortensen HB, Hougaard P. Comparison of metabolic control in a cross-sectional study of 2.873 children and adolescents with IDDM from 18 countries. Diabetes Care 1997;20:714-20.
8. Silverstein J, Klingensmith G, Copeland K, et al. Care of children and adolescents with type 1 diabetes. A statement of the American Diabetes Association. Diabetes Care 2005;28:186-212.
9. Dorchy H. Dietary management for children and adolescents with diabetes mellitus: personal experience and recommendations. J Pediatr Endocrinol Metab 2003;16:131-48.
10. Phillip M, Battelino T, Rodriguez H, et al. Consensus statement. Use of insulin pump therapy in the pediatricage-group. Diabetes Care, 2007 Mar 19; [Epub ahead of print].
11. Nimri R, Weintrob N, Benzaquen H, et al. Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study. Pediatrics 2006;117(6):2126-31.
12. Donne T, Battelino T, Kordonouri O, et al. A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries. Pediatr Diabetes 2005;6(4):193-8.
13. Weinzimer SA, Ahern JH, Doyle EA, et al. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics 2004;114(6):1601- 5.
14. Mortensen H, Lindholm A, Olsen B, et al. Rapid appearance and onset of action of insulin aspart in paediatric subjects with type 1 diabetes. Eur J Pediatr 2000;159:483-8.
15. Danne T, Becker RH, Heise T, et al. Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes. Diabetes Care 2005;28(9):2100-5.
16. Acerini CL, Cheetham TD, Edge JA, et al. Both insulin sensitivity and insulin clearance in children and young adults with type I (insulin-dependent) diabetes vary with growth hormone concentrations and with age. Diabetologia 2000;43:61-8.
17. Danne T, Aman J, Schober E, et al. A comparison of postprandial and pre-prandial administration of insulin aspart in children and adolescents with type 1 diabetes. Diabetes Care 2003;26:2359-84.
18. Danne T, Rastam J, Odendahl R, et al. Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal-bolus scheme with NPH insulin in a twelve week crossover-study of preschool children with type 1 diabetes. Pediatr Diabetes 2007 (in press).
19. Danne T, Lupke K, Walte K, et al. Insulin detemir is characterized by a consistent pharmacokinetic profile across age-groups in children, adolescents, and adults with type 1 diabetes. Diabetes Care 2003;26:3087-92.
20. Alemzadeh R, Berhe T, Wyatt DT. Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschool-aged children with type 1 diabetes mellitus. Pediatrics 2005; 115(5):1320-4.
21. Chase HP, Dixon B, Pearson J, et al. Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin. J Pediatr 2003;143(6):737-40.
22. Schrober E, Schoenle E, Can Dyk J, et al. Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2002;15(4):369-76.
23. Robertson K, Schönle E, Gucev Z, et al. Benefits of insulin detemir over NPH insulin in children and adolescents with type 1 diabetes: lower and more predictable fasting plasma glucose and lower risk of nocturnal hypoglycaemia [Abstract P66]. Diabet Med 2005;22(Suppl 2):45.
24. Kordonouri O, Datz N, Hoeffe J, et al. Efficacy and safety of bedtime insulin detemir vs. insulin semilente in children, adolescents, and young adults with type 1 diabetes. A randomized, open-label, cross-over study [abstract]. Pediatr Diabetes 2006;7(Suppl 5):68-9.
25. von Sengbusch S, Muller-Godeffroy E, Hager S, et al. Mobile diabetes education and care: intervention for children and young people with type 1 diabetes in rural areas of northern Germany. Diabet Med 2006;23:122-7.
26. Skinner TC, John M, Hampson SE. Social support and personal models of diabetes as predictors of self-care and well-being: a longitudinal study of adolescents with diabetes. J Pediatr Psychol 2000;25:257-67.
27. Shalitin S, Phillip M. Closing the loop: combining insulin pumps and glucose sensors in children with type 1 diabetes mellitus. Pediatr Diabetes 2006;7(Suppl 4):45-9.
28. Anderson B, Ho J, Brackett J, et al. Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus. J Pediatr 1997;130:257-65.
29. American Diabetes Association. Diabetes care in the school and day care setting (position statement). Diabetes Care 2004;27(Suppl 1):S122-8.
30. Lange K, Danne T, Kordonouri O, et al. Diabetes in childhood: everyday burden and professional consequences for parents. Dtsch Med Wochenschr 2004;129(20):1130-4.
31. Svoren BM, Butler D, Levine BS, et al. Reducing acute adverse outcomes in youths with type 1 diabetes: a randomized, controlled trial. Pediatrics 2003;112:914-22.
32. Howells L, Wilson AC, Skinner TC, et al. A randomized control trial of the effect of negotiated telephone support on glycaemic control in young people with type 1 diabetes. Diabet Med 2002;19:643-8.
33. Chase HP, Lockspeiser T, Peery B, et al. The impact of the Diabetes Control and Complications Trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes. Diabetes Care 2001;24:430-4.
34. Danne T, Mortensen HB, Hougaard P, et al. Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidore Study Group. Diabetes Care 2001;24:1342-7.
35. Danne T, von Schutz W, Lange K, et al. Current practice of insulin pump therapy in children and adolescents - the Hannover recipe. Pediatr Diabetes 2006;7(Suppl 4):25-31.
36. Swift PGF, de Beaufort CE, Skinner TC, on behalf of the Hvidore Study Group. Services provided by the diabetes team: do they effect the glycemic outcome? [abstract]. Pediatr Diabetes 2006;7(Suppl 5): 19.
37. Jeha GS, Heptulla RA. Newer therapeutic options for children with diabetes mellitus: theoretical and practical considerations. Pediatr Diabetes 2006;7(2):122-38.
38. Voltarelli JC, Couri CE, Stracieri AB, et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2007;297:1568-76.
39. Keymeuten B, Vandemeulebroucke E, Ziegler AG, et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 2005;352:2598-608.